FIELD: medicine. SUBSTANCE: in biosample one should detect super-expression of protein-regulator of cellular cycle as cycline-dependent kinase p16 inhibitor. The innovation in question, also, includes the kit to perform this method including a reagent improving expression of cycline-dependent kinase p16 inhibitor and generally accepted additional substances. EFFECT: shortened terms for diagnostics. 7 cl, 2 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSIS METHOD FOR USING A SOLUTION | 2003 |
|
RU2315312C2 |
| METHOD FOR NEOPLASTIC DISEASE DETECTION ON THE BASIS OF SOLUBILISED PHYSIOLOGICAL SAMPLE | 2004 |
|
RU2405158C2 |
| PEPTIDES OBTAINED FROM p16 FOR PREVENTION AND TREATMENT OF HPV-ASSOCIATED TUMOURS AND OTHER TUMOURS EXPRESSING p16 | 2012 |
|
RU2626542C2 |
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF CERVICAL DYSPLASIA | 2019 |
|
RU2704966C1 |
| METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CERVICAL DYSPLASIA AND CERVICAL CANCER | 2012 |
|
RU2538618C2 |
| METHOD FOR MULTICOLORED IMMUNE-CYTOCHEMICAL DIAGNOSTICS OF PARANEOPLASIA OF CERVIX UTERI | 2020 |
|
RU2753236C1 |
| DIAGNOSTIC TECHNIQUE FOR CERVICAL INTRAEPITHELIAL NEOPLASMS | 2010 |
|
RU2464570C2 |
| MSI-SPECIFIC PEPTIDES WITH SHIFTED READING FRAME (SRF) FOR PREVENTION AND TREATMENT OF CANCER | 2012 |
|
RU2644677C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSPLASTIC PROCESSES OF CERVIX | 2008 |
|
RU2395281C2 |
